This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): KS-01-017
Description: KS-01-017 is a dual regulator of glucose and lipids, which is expected to have lipid effects similar to Niaspan.
Deal Structure: In December 2006, Abbott Laboratories closed its acquisition of Kos Pharmaceuticals.
Additional information available to subscribers only: